These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 17186330)
1. Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure. Iida S; Kohno K; Yoshimura J; Ueda S; Usui M; Miyazaki H; Nishida H; Tamaki K; Okuda S Clin Exp Nephrol; 2006 Dec; 10(4):262-7. PubMed ID: 17186330 [TBL] [Abstract][Full Text] [Related]
2. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673 [TBL] [Abstract][Full Text] [Related]
3. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Miyazaki T; Aoyama I; Ise M; Seo H; Niwa T Nephrol Dial Transplant; 2000 Nov; 15(11):1773-81. PubMed ID: 11071964 [TBL] [Abstract][Full Text] [Related]
4. Preventive effects of an oral sorbent on nephropathy in rats. Aoyama I; Miyazaki T; Niwa T Miner Electrolyte Metab; 1999; 25(4-6):365-72. PubMed ID: 10681668 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats. Aoyama I; Shimokata K; Niwa T Nephron; 2002 Mar; 90(3):297-312. PubMed ID: 11867951 [TBL] [Abstract][Full Text] [Related]
6. Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure. Niwa T; Aoyama I; Takayama F; Tsukushi S; Miyazaki T; Owada A; Shiigai T Miner Electrolyte Metab; 1999; 25(1-2):118-22. PubMed ID: 10207273 [TBL] [Abstract][Full Text] [Related]
7. An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. Shimoishi K; Anraku M; Kitamura K; Tasaki Y; Taguchi K; Hashimoto M; Fukunaga E; Maruyama T; Otagiri M Pharm Res; 2007 Jul; 24(7):1283-9. PubMed ID: 17387602 [TBL] [Abstract][Full Text] [Related]
8. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients. Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure. Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984 [TBL] [Abstract][Full Text] [Related]
10. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Owada A; Nakao M; Koike J; Ujiie K; Tomita K; Shiigai T Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455 [TBL] [Abstract][Full Text] [Related]
11. An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. Aoyama I; Niwa T Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S7-S12. PubMed ID: 11158853 [TBL] [Abstract][Full Text] [Related]
12. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Niwa T; Tsukushi S; Ise M; Miyazaki T; Tsubakihara Y; Owada A; Shiigai T Miner Electrolyte Metab; 1997; 23(3-6):179-84. PubMed ID: 9387112 [TBL] [Abstract][Full Text] [Related]
13. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF. Sanaka T; Fujimoto K; Niwayama J; Nishimura H; Naito T; Higuchi C; Akizawa T; Koide K; Koshikawa S Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949 [TBL] [Abstract][Full Text] [Related]
14. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients. Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840 [TBL] [Abstract][Full Text] [Related]